Technology Cellphire has developed a proprietary method for the stabilization of blood in the dry state. First application of this technology will be the long term stabilization of blood platelets (freeze-dried platelets). We are developing freeze-dried stabilized platelets for hemostasis and wound-healing therapies, and as a control reagent for platelet function diagnostics. Cellphire's first platelet stabilization product is Thrombogent™, an easily rehydrated platelet product for use as a control reagent for hematology and clinical diagnostic analysis and drug development. An additional Cellphire product is Thromboderm™, an advanced freeze-dried, platelet based topical hemostatic agent that will for the first time enable clotting, sealing and wound healing in the same application. Thromboderm™ can be incorporated with a variety of healing materials such as collagen and/or different types of polymers and applied through a dry bandage. Cellphire's Thrombosomes® are a freeze-dried, functional platelet transfusion hemostatic agent. Thrombosomes® will be targeted for cardiopulmonary bypass and emergency trauma and in indications that require costly coagulation therapies and be packaged in a dry powder ready for immediate use or for long term stockpiling.